Westwood Holdings Group Inc. Grows Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Westwood Holdings Group Inc. raised its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.1% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 908,460 shares of the company’s stock after purchasing an additional 1,205 shares during the period. Westwood Holdings Group Inc. owned 1.83% of Prestige Consumer Healthcare worth $62,547,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of PBH. Congress Wealth Management LLC DE boosted its holdings in Prestige Consumer Healthcare by 246.1% in the fourth quarter. Congress Wealth Management LLC DE now owns 114,220 shares of the company’s stock valued at $6,993,000 after acquiring an additional 81,215 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of Prestige Consumer Healthcare by 5.3% in the 4th quarter. The Manufacturers Life Insurance Company now owns 605,376 shares of the company’s stock valued at $37,061,000 after acquiring an additional 30,288 shares during the period. State Board of Administration of Florida Retirement System lifted its holdings in shares of Prestige Consumer Healthcare by 77.4% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock valued at $1,830,000 after acquiring an additional 11,000 shares in the last quarter. Congress Asset Management Co. MA boosted its position in Prestige Consumer Healthcare by 596.2% during the 4th quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company’s stock worth $41,584,000 after purchasing an additional 581,685 shares during the period. Finally, Norges Bank acquired a new stake in Prestige Consumer Healthcare in the 4th quarter valued at $27,739,000. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

Shares of PBH stock opened at $73.01 on Friday. The firm has a market capitalization of $3.62 billion, a P/E ratio of 17.51, a P/E/G ratio of 2.08 and a beta of 0.48. Prestige Consumer Healthcare Inc. has a 12 month low of $56.34 and a 12 month high of $75.80. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The company’s fifty day moving average price is $71.22 and its two-hundred day moving average price is $69.67.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The business had revenue of $267.10 million during the quarter, compared to analyst estimates of $260.54 million. During the same quarter in the previous year, the firm earned $1.06 earnings per share. The business’s revenue was down 4.4% compared to the same quarter last year. On average, research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, DA Davidson increased their target price on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $98.75.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.